Financial Year |
March 31 2023 |
Monetary Funds |
2,725,568,233.29 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
80,830,670.23 |
Accounts Receivable |
2,256,872,229.72 |
Advances to Suppliers |
49,884,253.77 |
Other Receivables |
36,173,344.89 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
3,323,360,934.89 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
20,200,000.00 |
Other Current Assets |
48,535,779.38 |
Total Current Assets |
9,224,642,341.92 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
53,300,000.00 |
Long-term Equity Investment |
943,856,299.19 |
Investment Properties |
-- |
Fixed Assetes |
4,280,084,978.78 |
Under-construction Projects |
1,576,271,834.07 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
267,875,278.56 |
R&D expenses |
-- |
Goodwill |
619,947.54 |
Long-Term Deferred and Prepaid Expenses |
99,184,031.67 |
Deferred Income Tax Assets |
136,592,966.25 |
Other Non-Current Assets |
244,304,596.97 |
Sub-Total of Non-Current Assets |
8,837,988,920.10 |
Total Assets |
18,062,631,262.02 |
Short-Term Loans |
2,441,676,007.58 |
Trading Financial liabilities |
1,923,263.71 |
Notes Payable |
139,066,608.71 |
Accounts Payable |
1,649,327,276.74 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
169,944,457.64 |
Taxes Payable |
126,034,804.48 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
14,732,387.30 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
985,519,042.19 |
Other Current Liabilities |
3,543,531.61 |
Sub-Total of Current Liabilities |
5,565,072,800.23 |
Long-term Loans |
2,573,812,870.33 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
422,079,158.15 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
158,860,738.06 |
Other Non-Current Liabilities |
417,915,555.26 |
Sub-Total of Non-Current Liabilities |
3,705,921,438.60 |
Total Liabilities |
9,270,994,238.83 |
Paid-In Capital(Or Share Stock) |
1,416,071,845.00 |
Capital Surplus |
2,383,052,048.81 |
Surplus Reserve |
449,324,385.45 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
3,526,839,068.56 |
Minority Stockholder's Interest |
1,010,069,490.64 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,781,567,532.55 |
Owner's Equity(Stockholder's Equity) |
8,791,637,023.19 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
18,062,631,262.02 |